TuHURA Biosciences, Inc. - Common Stock

Share · US8989201038 · HURA (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

04.02.2026 23:38

Current Prices from TuHURA Biosciences, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	HURA	USD	04.02.2026 23:38	0,43 USD	-0,04 USD -7,78 %
Frankfurt	PL3.F	EUR	04.02.2026 07:04	0,37 EUR	-0,04 EUR -9,71 %

Share Float & Liquidity

Free Float 57,36 %

Shares Float 32,4 M

Shares Outstanding 56,48 M

Company Profile for TuHURA Biosciences, Inc. - Common Stock Share

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

AI Analysis of TuHURA Biosciences, Inc. - Common Stock

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of TuHURA Biosciences, Inc. - Common Stock

No AI threads available for this company yet.

Company Data

Name TuHURA Biosciences, Inc. - Common Stock

Company TuHURA Biosciences, Inc.

Symbol HURA

Website http://www.tuhurabio.com

Primary Exchange

NASDAQ

ISIN US8989201038

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO James A. Bianco

Market Capitalization 26 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 10500 University Center Drive, Tampa

IPO Date 2013-02-22

ID Changes

Date	From	To
18.10.2024	KTRA	HURA
20.08.2020	DMPI	KTRA

Ticker Symbols

Name	Symbol
Frankfurt	PL3.F
NASDAQ	HURA

More Shares

Investors who hold TuHURA Biosciences, Inc. - Common Stock also have the following shares in their portfolio:

ANGLIAN WATER SERVICES FINANCING PLC 4.394%CLS A RPI SNR GTD REG BDS 01/04/28 Bond

SALUS D.D. INH. B Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog